BioSpace News Archive

Business

Amarin Slashes More than 50% of Sales Force in Digital Marketing Approach

There are roughly 750 sales representatives for Amarin at present, which the company intends to whittle down to 300 as it adopts a more digital approach to marketing.

September 24, 2021
·
2 min read
·
Vanessa Doctor, RN
Business

Top 10 US Biopharma Series A Rounds of 2021 – So Far!

The United States has seen companies launching left and right. Check out the top 10 biopharma Series A rounds in the U.S. so far this year.

September 24, 2021
·
4 min read
·
Ellen Bombela
FDA

CDC Breaks with Advisory Panel on Boosters, Recommends Broader Access

A day after the FDA authorized a COVID-19 booster dose of the Pfizer-BioNTech vaccine, a U.S. Centers for Disease Control and Prevention advisory committee voted in support.

September 24, 2021
·
4 min read
·
Mark Terry
Experts Recommend Taking Race Out of the Equation for Kidney Disease

The National Kidney Foundation and the American Society of Nephrology recommend removing race from the equation in the assessment of kidney disease.

September 24, 2021
·
3 min read
·
Kate Goodwin
BioMidwest

Clinical Catch-Up: September 20-24

There was still some carryover from the European Society of Medical Oncology Congress 2021, but there was plenty of other clinical trial news last week. Here’s a look.

September 24, 2021
·
12 min read
·
Mark Terry
Policy

Pharma in the Courts: Takeda, AbbVie, RedHill, Pfizer and Gilead

Aside from the fraud trial of Theranos founder Elizabeth Holmes, other court-related cases are taking place, including between Takeda and AbbVie over cancer drug, Lupron.

September 24, 2021
·
3 min read
·
Alex Keown
Researchers Turn Back the Clock on Heart Cells in Mice

Researchers from the Max Planck Institute for Heart and Lung Research reportedly achieved positive results after returning adult cardiomyocytes to their fetal-like state in mouse models.

September 24, 2021
·
2 min read
·
Vanessa Doctor, RN
Business

Former Principia CEO Tapped to Lead Esker Therapeutics

Esker Therapeutics tapped Martin Babler to helm the company after founding CEO June Lee has stepped away to pursue other opportunities.

September 24, 2021
·
2 min read
·
Alex Keown
Drug Development

New Capricor Data Signals Hope for Difficult-to-Treat Duchenne Muscular Dystrophy Population

Capricor announced positive final data from the HOPE-2 trial of its drug candidate. It showed a slowing of disease progression in Duchenne muscular dystrophy patients.

September 24, 2021
·
2 min read
·
Heather McKenzie
Synchronized Cardioversion Market: Surge in Incidence Rate of Atrial Fibrillation is Expected to Drive the Market

Synchronized cardioversion is a low energy shock that uses a sensor to provide electricity that is synchronized with the highest point of the QRS complex.

September 24, 2021
·
6 min read